The content is available as a PDF (245.2 KB).
. 2022 Jun 1;81:S503–S504. doi: 10.1016/S0302-2838(22)00411-0
E-Consent – an innovative solution to maintain recruitment momentum in clinical trials during the COVID-19 pandemic
R Almeida-Magana
, J Grierson
, H Maroof
, R Clow
, E Dineen
, T Al-Hammouri
, N Muirhead
, C Brew-Graves
, J Kelly
, G Shaw
R Almeida-Magana
Find articles by R Almeida-Magana
J Grierson
Find articles by J Grierson
H Maroof
Find articles by H Maroof
R Clow
Find articles by R Clow
E Dineen
Find articles by E Dineen
T Al-Hammouri
Find articles by T Al-Hammouri
N Muirhead
Find articles by N Muirhead
C Brew-Graves
Find articles by C Brew-Graves
J Kelly
Find articles by J Kelly
G Shaw
Find articles by G Shaw
Issue date 2022 Feb.
Copyright © 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved. Published by Elsevier B.V. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9155268